Santa Cruz Biotechnology

CD8-α (D-9) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; CD8-α Antibody (D-9) is an IgG2a κ mouse monoclonal CD8-alpha antibody (also designated MAL antibody, T-lymphocyte differentiation antigen T8/Leu-2 antibody or CD8A antibody) that detects the CD8-alpha protein of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA. CD8-α Antibody (D-9) is available as both the non-conjugated anti-CD8-alpha antibody form, as well as multiple conjugated forms of anti-CD8-alpha antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The T cell receptor (TCR) is a heterodimer composed of either α and β or γ and δ chains. CD3 chains and the CD4 or CD8 (CD8-α and CD8-β) co-receptors are also required for efficient signal transduction through the TCR. The TCR is expressed on T helper and T cytotoxic cells that can be distinguished by their expression of CD4 and CD8 proteins; T helper cells express CD4 proteins and T cytotoxic cells display CD8 proteins. CD8s are cell surface glycoproteins that exist as two chain complex (αα or αβ) receptors that bind class I MHC molecules presented by the antigen-presenting cell (APC). A primary function of CD8 proteins is to facilitate antigen recognition by the TCR and to strengthen the avidity of the TCR-antigen interactions. An additional role for CD8-expressing T cells may be to maintain low levels of HIV expression.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.